Investigating oral microbiome dynamics in chronic kidney disease and post-transplantation in continuous culture

被引:0
|
作者
Campbell, Paul M. [1 ]
Willmott, Thomas [1 ]
Summers, Angela [2 ]
Knight, Christopher G. [3 ]
Humphreys, Gavin J. [1 ]
Konkel, Joanne E. [4 ]
Augustine, Titus [2 ]
Mcbain, Andrew J. [1 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Manchester, England
[2] Manchester Acad Hlth Sci Ctr, Manchester Univ Hosp NHS Fdn Trust, Dept Renal & Pancreat Transplantat, Manchester, England
[3] Univ Manchester, Fac Sci & Engn, Sch Nat Sci, Manchester, England
[4] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, England
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 11期
基金
英国医学研究理事会;
关键词
urea; oral microbiome; kidney transplantation; chronic kidney disease; ANTIMICROBIAL SUSCEPTIBILITY; DENTAL BIOFILMS; PH; BACTERIA; STREPTOCOCCI; ENZYMES; HEALTH;
D O I
10.1128/spectrum.00598-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The oral microbiome is influenced by environmental factors in chronic kidney disease and following kidney transplantation affecting microbial composition, which may have implications for health and recovery. A major driver of oral microbiome perturbation is the accumulation of urea in saliva. We have modelled increased salivary urea concentrations associated with CKD and subsequent reductions that may occur post-transplantation. Oral microbiota were established in constant-depth film fermenters by inoculation with saliva. Duplicate validation runs were maintained with artificial saliva with baseline urea concentrations (0.205 mg/mL) for 21 days. Triplicate treatment runs were then done with baseline urea for 10 days (healthy phase) before urea was increased for 10 days to reflect CKD concentrations (0.92 mg/mL) (CKD phase). This was followed by reversion to baseline urea concentrations (post-transplant phase). Biofilms in primary validation runs reached dynamic stability within 5 days according to viable counting. DNA sequence data indicated minimal taxonomic variation over time and between low and high urea treatments despite background noise indicating changes in bacteria belonging to the family Gemellaceae and the genera TG5 and Leptotrichia. Significant differences in alpha and beta diversity occurred between low and high urea states but not following reversion to a low urea environment. Increased abundance of the TG5 was detected in late model phases, despite apparent count stability, and independent of changes in urea concentrations.IMPORTANCEThis study investigates dynamic changes in the oral microbiome associated with changes in salivary urea concentration, an important factor in chronic kidney disease (CKD). The in vitro system modeled increased urea concentrations and subsequent reductions post-transplantation. The study provides insight into the oral microbial shifts during different simulated clinical phases. Understanding these dynamics is crucial for advancing our comprehension of CKD-associated oral microbiome variations and their potential impact on patient well-being and recovery. This study investigates dynamic changes in the oral microbiome associated with changes in salivary urea concentration, an important factor in chronic kidney disease (CKD). The in vitro system modeled increased urea concentrations and subsequent reductions post-transplantation. The study provides insight into the oral microbial shifts during different simulated clinical phases. Understanding these dynamics is crucial for advancing our comprehension of CKD-associated oral microbiome variations and their potential impact on patient well-being and recovery.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Post-transplantation dynamics of non-HLA antibodies and early panel intensity as predictors of ABMR in kidney transplantation
    Tan, Jinghong
    Huang, Mingchuan
    Wu, Wenrui
    Zhang, Huanxi
    Liu, Longshan
    Wang, Changxi
    TRANSPLANTATION, 2024, 108 (9S)
  • [22] Isolated Colonic Post-Transplantation Lymphoproliferative Disease
    Fredrick, Thomas W.
    Ramos, Guilherme Piovezani
    Loftus Jr, Edward, V
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (04) : e648 - e648
  • [23] Characteristics and Risk Factors of Post-Transplantation Diabetes Mellitus After Kidney Transplantation
    He, C. Y.
    Bi, H. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S318 - S318
  • [24] Risk factors for and management of post-transplantation cardiovascular disease
    Fellström, B
    BIODRUGS, 2001, 15 (04) : 261 - 278
  • [25] Gut microbiome in chronic kidney disease
    Wing, Maria R.
    Patel, Samir S.
    Ramezani, Ali
    Raj, Dominic S.
    EXPERIMENTAL PHYSIOLOGY, 2016, 101 (04) : 471 - 477
  • [26] Duodenal microbiome in chronic kidney disease
    Kondo, Masahiro
    Torisu, Takehiro
    Nagasue, Tomohiro
    Shibata, Hiroki
    Umeno, Junji
    Kawasaki, Keisuke
    Fujioka, Shin
    Matsuno, Yuichi
    Moriyama, Tomohiko
    Kitazono, Takanari
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (04) : 263 - 272
  • [27] Duodenal microbiome in chronic kidney disease
    Masahiro Kondo
    Takehiro Torisu
    Tomohiro Nagasue
    Hiroki Shibata
    Junji Umeno
    Keisuke Kawasaki
    Shin Fujioka
    Yuichi Matsuno
    Tomohiko Moriyama
    Takanari Kitazono
    Clinical and Experimental Nephrology, 2024, 28 : 263 - 272
  • [28] Chronic kidney disease and the gut microbiome
    Hobby, Gerren P.
    Karaduta, Oleg
    Dusio, Giuseppina F.
    Singh, Manisha
    Zybailov, Boris L.
    Arthur, John M.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 316 (06) : F1211 - F1217
  • [29] Gut Microbiome in Chronic Kidney Disease
    R. G. Armani
    A. Ramezani
    A. Yasir
    S. Sharama
    M. E. F. Canziani
    D. S. Raj
    Current Hypertension Reports, 2017, 19
  • [30] Gut Microbiome in Chronic Kidney Disease
    Armani, R. G.
    Ramezani, A.
    Yasir, A.
    Sharama, S.
    Canziani, M. E. F.
    Raj, D. S.
    CURRENT HYPERTENSION REPORTS, 2017, 19 (04)